179
Views
12
CrossRef citations to date
0
Altmetric
Case Reports

RESPONSE TO RITUXIMAB AND PREDNISOLONE FOR OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME IN A CHILD WITH GANGLIONEUROBLASTOMA

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 756-761 | Published online: 09 Jul 2009

REFERENCES

  • Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from Children's Cancer Group Study. Med Pediatr Oncol 2001; 36: 612–622
  • Kramer K, Pranzatelli MR. Management of neurologic complications. Neuroblastoma, NKV Cheung, SL Cohn. Springer-Verlag, Berlin 2005; 213–222
  • Gambini C, Conte M, Bernini G, et al. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases. Virchows Arch 2003; 442: 555–562
  • Pranzatelli MR, Tate ED, Travelstead AL, et al. Rituximab (anti-CD 20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol 2006; 28: 585–593
  • Bell J, Moran C, Blatt J. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus. Pediatr Blood Cancer 2006, DOI 10.1002/pbc.20899
  • Ertle F, Behnisch W, Al Mulla NA, et al. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses. Pediatr Blood Cancer 2007, DOI 10.1002/pbc.21107
  • Burke MJ, Cohn SL. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma. Pediatr Blood Cancer 2006, DOI 10.1002/pbc.21009
  • Rostásy K, Wilken B, Baumann M, et al. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome. Neuropediatrics 2006; 37: 291–295
  • Emir S, Akyüz C, Büyükpamukcu M. Treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone. Med Pediatr Oncol 2003; 40: 139
  • Chang BH, Koch T, Hopkins K, Malempati S. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus. Pediatr Neurol 2006; 35: 213–215
  • Pranzatelli MR, Tate ED, Travelstead AL, Longee D. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome. Pediatrics 2005; 115: e115–e119
  • Wong A. An update on opsoclonus. Curr Opin Neurol 2007; 20: 25–31
  • Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome. Eur J Pediatr 2007; 166: 359–363

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.